ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-7674

Improper Input Validation vulnerability in Roche Diagnostics navify Monitoring allows an attacker to manipulate input data, which may lead to a denial of service (DoS) due to negat

Published Aug 5, 2025 · catalog updated Aug 5, 2025 · Roche Diagnostics navify Monitoring

Last checked Oct 29, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2025-7674. EPSS is 0.30%. Act only if a listed version of Roche Diagnostics navify Monitoring is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High7.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.30%
Remediation
Version ranges on file
Affected products
vendor Roche Diagnostics navify Monitoring 0 <1.08.00

Improper Input Validation vulnerability in Roche Diagnostics navify Monitoring allows an attacker to manipulate input data, which may lead to a denial of service (DoS) due to negatively impacting the server's performance. This vulnerability has no impact on data confidentiality or integrity. This issue affects navify Monitoring before 1.08.00.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Roche Diagnostics navify Monitoring 0 <1.08.000 <1.08.00

How to fix CVE-2025-7674

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-7674. EPSS is 0.30%. Act only if a listed version of Roche Diagnostics navify Monitoring is installed.

Which versions are affected?

Compare what you have installed with Roche Diagnostics navify Monitoring 0 <1.08.00 0 <1.08.00. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.30%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Aug 5, 2025 · EUVD

    Detected

    Improper Input Validation vulnerability in Roche Diagnostics navify Monitoring allows an attacker to manipulate input data, which may lead to a denial of service (DoS) due to negatively impacting the server's performance. This vulnerability has no impact on data confidentiality or integrity. This issue affects navify Monitoring before 1.08.00.

  2. Aug 5, 2025 · EUVD

    Updated

    Improper Input Validation vulnerability in Roche Diagnostics navify Monitoring allows an attacker to manipulate input data, which may lead to a denial of service (DoS) due to negatively impacting the server's performance. This vulnerability has no impact on data confidentiality or integrity. This issue affects navify Monitoring before 1.08.00.

Sources

  • CVE.orgVulnerability recordCVE-2025-7674

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-7674

    30-day exploitation probability 0.30%

    first.org
  • EUVDVulnerability recordEUVD-2025-23643

    Improper Input Validation vulnerability in Roche Diagnostics navify Monitoring allows an attacker to manipulate input data, which may lead to a denial of service (DoS) due to negatively impacting the server's performance. This vulnerability has no impact on data confidentiality o

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 29, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • FIRST EPSSOct 29, 2026
  • CVE.orgOct 21, 2026
  • EUVDOct 20, 2026